Najib T. Ayas
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Najib T. Ayas has a total of 51 co-authors. Here are the top co-authors by number of shared publications:
Arsalan Butt
Sleep Disorders Program, University of British Columbia Hospital, Vancouver, Canada
3 shared publicationsJohn Fleetham
University of British Columbia, Vancouver, Canada
3 shared publicationsRupi Cheema
Sleep Disorders Program, University of British Columbia Hospital, Vancouver, Canada
3 shared publicationsA. T. Mulgrew
University of British Columbia
2 shared publicationsAlan Mulgrew
University of British Columbia, Vancouver, Canada
2 shared publicationsC. F. Ryan
University of British Columbia
2 shared publications
Latest Publications
- Open Access
- 15 July 2021
- Published by Springer Nature in Sleep Science and Practice
- Vol. 5 (1) , 1-8
Revisiting level II sleep studies in the era of COVID-19: a theoretical economic decision model in patients with suspected obstructive sleep apnea
Background: The recent pandemic has made it more challenging to assess patients with suspected obstructive sleep apnea (OSA) with in laboratory polysomnography (PSG) due to concerns of patient and staff safety. The purpose of this study was to assess how Level II sleep studies (LII, full PSG in the home) might be utilized in diagnostic algorithms of suspected OSA using a theoretical decision model. Methods: We examined four diagnostic algorithms for suspected OSA: an initial PSG approach, an initial LII approach, an initial Level III approach (LIII, limited channel home sleep study) followed by PSG if needed, and an initial LIII approach followed by LII if needed. Costs per patient assessed was calculated as a function of pretest OSA probability and a variety of other variables (e.g. costs of tests, failure rate of LIII/LII, sensitivity/specificity of LIII). The situation in British Columbia was used as a case study. Results: The variation in cost per test was calculated for each algorithm as a function of the above variables. For British Columbia, initial LII was the least costly across a broad range of pretest OSA probabilities (< 0.80) while initial LIII followed by LII as needed was least costly at very high pretest probability (> 0.8). In patients with a pretest OSA probability of 0.5, costs per patient for initial PSG, initial LII, initial LIII followed by PSG, and initial LIII followed by LII were: $588, $417, $607, and $481 respectively. Conclusions: Using a theoretical decision model, we developed a preliminary cost framework to assess the potential role of LII studies in OSA assessment. Across a broad range of patient pretest probabilities, initial LII studies may provide substantial cost advantages. LII studies might be especially useful during pandemics as they combine the extensive physiologic information characteristic of PSG with the ability to avoid in-laboratory stays. More empiric studies need to be done to test these different algorithms.
- 15 July 2021
- Published by Springer Nature in Sleep Science and Practice
- Vol. 5 (1) , 1-8
Open AccessRevisiting level II sleep studies in the era of COVID-19: a theoretical economic decision model in patients with suspected obstructive sleep apnea
Background: The recent pandemic has made it more challenging to assess patients with suspected obstructive sleep apnea (OSA) with in laboratory polysomnography (PSG) due to concerns of patient and staff safety. The purpose of this study was to assess how Level II sleep studies (LII, full PSG in the home) might be utilized in diagnostic algorithms of suspected OSA using a theoretical decision model. Methods: We examined four diagnostic algorithms for suspected OSA: an initial PSG approach, an initial LII approach, an initial Level III approach (LIII, limited channel home sleep study) followed by PSG if needed, and an initial LIII approach followed by LII if needed. Costs per patient assessed was calculated as a function of pretest OSA probability and a variety of other variables (e.g. costs of tests, failure rate of LIII/LII, sensitivity/specificity of LIII). The situation in British Columbia was used as a case study. Results: The variation in cost per test was calculated for each algorithm as a function of the above variables. For British Columbia, initial LII was the least costly across a broad range of pretest OSA probabilities (< 0.80) while initial LIII followed by LII as needed was least costly at very high pretest probability (> 0.8). In patients with a pretest OSA probability of 0.5, costs per patient for initial PSG, initial LII, initial LIII followed by PSG, and initial LIII followed by LII were: $588, $417, $607, and $481 respectively. Conclusions: Using a theoretical decision model, we developed a preliminary cost framework to assess the potential role of LII studies in OSA assessment. Across a broad range of patient pretest probabilities, initial LII studies may provide substantial cost advantages. LII studies might be especially useful during pandemics as they combine the extensive physiologic information characteristic of PSG with the ability to avoid in-laboratory stays. More empiric studies need to be done to test these different algorithms.
- 1 March 2015
- Published by Wolters Kluwer Health in Journal of Patient Safety
- Vol. 11 (1) , 23-27
Attributable Length of Stay and Mortality of Major Bleeding as a Complication of Therapeutic Anticoagulation in the Intensive Care Unit
The aim of this study was to determine the attributable length of stay and mortality due to bleeding as a complication of therapeutic anticoagulation in intensive care unit (ICU) patients.Charts of patients from 7 ICUs in British Columbia were screened daily for the occurrence of major bleeding while receiving therapeutic heparin. To determine attributable length of stay and mortality, a matched and unmatched cohort design as well as multivariate analysis were used. We included only patients who were started on anticoagulation on or after day 2 in the ICU.Between 2006 and 2009, a total of 868 patients were started on therapeutic anticoagulation and 139 bled. One hundred five patients who bled were matched to 261 controls. In the matched analysis after adjustment for potential confounders, each bleeding event was associated with an increase in ICU length of stay (hazard ratio for ICU discharge, 0.47; 95% confidence interval, 0.38-0.57; attributable ICU length of stay of 13.8 days). Hospital length of stay was also significantly increased. In the entire cohort analysis, bleeding was also associated with increased ICU length of stay (hazard ratio, 0.59; confidence interval, 0.48-0.72; attributable stay of 6.1 days) and increased hospital length of stay. In both analyses, bleeding was not associated with hospital mortality.Major bleeding while receiving anticoagulation is associated with a substantial increase in ICU and hospital length of stay.
- 1 March 2015
- Published by Wolters Kluwer Health in Journal of Patient Safety
- Vol. 11 (1) , 23-27
Attributable Length of Stay and Mortality of Major Bleeding as a Complication of Therapeutic Anticoagulation in the Intensive Care Unit
The aim of this study was to determine the attributable length of stay and mortality due to bleeding as a complication of therapeutic anticoagulation in intensive care unit (ICU) patients.Charts of patients from 7 ICUs in British Columbia were screened daily for the occurrence of major bleeding while receiving therapeutic heparin. To determine attributable length of stay and mortality, a matched and unmatched cohort design as well as multivariate analysis were used. We included only patients who were started on anticoagulation on or after day 2 in the ICU.Between 2006 and 2009, a total of 868 patients were started on therapeutic anticoagulation and 139 bled. One hundred five patients who bled were matched to 261 controls. In the matched analysis after adjustment for potential confounders, each bleeding event was associated with an increase in ICU length of stay (hazard ratio for ICU discharge, 0.47; 95% confidence interval, 0.38-0.57; attributable ICU length of stay of 13.8 days). Hospital length of stay was also significantly increased. In the entire cohort analysis, bleeding was also associated with increased ICU length of stay (hazard ratio, 0.59; confidence interval, 0.48-0.72; attributable stay of 6.1 days) and increased hospital length of stay. In both analyses, bleeding was not associated with hospital mortality.Major bleeding while receiving anticoagulation is associated with a substantial increase in ICU and hospital length of stay.
- 1 March 2010
- Published by Elsevier in Sleep Medicine
- Vol. 11 (3) , 320-324
Initial use of portable monitoring versus polysomnography to confirm obstructive sleep apnea in symptomatic patients: An economic decision model
- 1 March 2010
- Published by Elsevier in Sleep Medicine
- Vol. 11 (3) , 320-324
Initial use of portable monitoring versus polysomnography to confirm obstructive sleep apnea in symptomatic patients: An economic decision model
- Open Access
- 1 February 2010
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 33 (2) , 143-144
If You Weigh Too Much, Maybe You Should Try Sleeping More
ANY VISIT TO A LOCAL SHOPPING CENTRE (OR SCHOOL) WILL SHOW YOU THAT OBESITY IS A MAJOR PUBLIC HEALTH PROBLEM IN NORTH AMERICA. Two major contributors to the high prevalence of obesity are inadequate exercise and excessive nutritional intake. However, many other factors have also been implicated including: increased maternal age, prenatal environment, viral infections, side effects of pharmaceuticals, assortative mating, endocrine disruptive chemicals, and the ambient thermal environment.1
- 1 February 2010
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 33 (2) , 143-144
Open AccessIf You Weigh Too Much, Maybe You Should Try Sleeping More
ANY VISIT TO A LOCAL SHOPPING CENTRE (OR SCHOOL) WILL SHOW YOU THAT OBESITY IS A MAJOR PUBLIC HEALTH PROBLEM IN NORTH AMERICA. Two major contributors to the high prevalence of obesity are inadequate exercise and excessive nutritional intake. However, many other factors have also been implicated including: increased maternal age, prenatal environment, viral infections, side effects of pharmaceuticals, assortative mating, endocrine disruptive chemicals, and the ambient thermal environment.1
- 21 October 2009
- Published by Springer Nature in Lung
- Vol. 188 (1) , 1-3
Can We Improve Sleep Quality by Changing the Way We Ventilate Patients?
- 21 October 2009
- Published by Springer Nature in Lung
- Vol. 188 (1) , 1-3
Can We Improve Sleep Quality by Changing the Way We Ventilate Patients?
- 5 May 2009
- Published by Springer Nature in Sleep and Breathing
- Vol. 13 (4) , 391-395
Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea
- 5 May 2009
- Published by Springer Nature in Sleep and Breathing
- Vol. 13 (4) , 391-395
Pro-atherogenic cytokine profile of patients with suspected obstructive sleep apnea
- 1 January 2009
- Published by IGI Global Scientific Publishing
- p. 350-375
Knowledge-Based Induction of Clinical Prediction Rules
This chapter describes how to integrate medical knowledge with purely inductive (data-driven) methods for the creation of clinical prediction rules. It addresses three issues: representation of medical knowledge, secondary analysis of medical data, and evaluation of automatically induced predictive models in the context of existing knowledge. To address the complexity of the domain knowledge, the authors have introduced a semio-fuzzy framework, which has its theoretical foundations in semiotics and fuzzy logic. This integrative framework has been applied to the creation of clinical prediction rules for the diagnosis of obstructive sleep apnea, a serious and under-diagnosed respiratory disorder. The authors use a semio-fuzzy approach (1) to construct a knowledge base for the definition of diagnostic criteria, predictors, and existing prediction rules; (2) to describe and analyze data sets used in the data mining process; and (3) to interpret the induced models in terms of confirmation, contradiction, and contribution to existing knowledge.
- 1 January 2009
- Published by IGI Global Scientific Publishing
- p. 350-375
Knowledge-Based Induction of Clinical Prediction Rules
This chapter describes how to integrate medical knowledge with purely inductive (data-driven) methods for the creation of clinical prediction rules. It addresses three issues: representation of medical knowledge, secondary analysis of medical data, and evaluation of automatically induced predictive models in the context of existing knowledge. To address the complexity of the domain knowledge, the authors have introduced a semio-fuzzy framework, which has its theoretical foundations in semiotics and fuzzy logic. This integrative framework has been applied to the creation of clinical prediction rules for the diagnosis of obstructive sleep apnea, a serious and under-diagnosed respiratory disorder. The authors use a semio-fuzzy approach (1) to construct a knowledge base for the definition of diagnostic criteria, predictors, and existing prediction rules; (2) to describe and analyze data sets used in the data mining process; and (3) to interpret the induced models in terms of confirmation, contradiction, and contribution to existing knowledge.
- 16 September 2008
- Published by Springer Nature in Lung
- Vol. 187 (1) , 17-22
The Impact of CPAP on Cardiovascular Biomarkers in Minimally Symptomatic Patients with Obstructive Sleep Apnea: A Pilot Feasibility Randomized Crossover Trial
Background Previous, largely uncontrolled studies demonstrated the substantial effects of continuous positive airway pressure ventilation (CPAP) on a variety of physiologic and biochemical markers known to be risk factors for cardiovascular disease in patients with obstructive sleep apnea (OSA). In this pilot crossover study, we assessed (1) the feasibility of using CPAP in a group of minimally symptomatic patients with OSA, assessed through patient compliance and (2) CPAP therapy’s effect on biomarkers in these patients. Methods We studied patients with minimal daytime sleepiness who were referred to the University of British Columbia’s Hospital Sleep Clinic with suspected OSA and an apnea-hypopnea index (AHI) > 15 events/h. Patients were randomized to either CPAP or no therapy for 4 weeks followed by a washout of 4 weeks, and then a crossover to the other intervention. Fasting morning blood and urine, 24-h blood pressure (BP) measurements, and endothelial function (peak flow-mediated dilation to nitroglycerin-mediated dilation ratio) were assessed before and after each study intervention. Results Nine adult male and four female patients were studied. Mean (SD) age was 55 (7) years, mean AHI = 27.9/h, mean Epworth Sleepiness Score = 6.8 (11/13 had a score < 10), and mean BMI = 31.1 kg/m2. Mean compliance with CPAP therapy was 5.53 h/night. Compared to no therapy, potential improvements were observed with CPAP for urinary microalbumin, norepinephrine, and epinephrine to creatinine ratios (decreased by 3.51 mg/mmol, 1.70 nmol/mmol, and 0.95 nmol/mmol, respectively); 24-h BP (systolic decreased by 3.60 mmHg, diastolic by 0.70 mmHg); homeostasis model for insulin resistance score (decreased by 1.11); and endothelial function (increased by 7.4%). However, none of the above differences was significant (p > 0.10). Conclusion In this pilot study there were potential improvements in a variety of cardiovascular biomarkers with CPAP. CPAP compliance was reasonably good even though patients were not particularly sleepy. Accordingly, larger randomized controlled trials in this area appear feasible and warranted.
- 16 September 2008
- Published by Springer Nature in Lung
- Vol. 187 (1) , 17-22
The Impact of CPAP on Cardiovascular Biomarkers in Minimally Symptomatic Patients with Obstructive Sleep Apnea: A Pilot Feasibility Randomized Crossover Trial
Background Previous, largely uncontrolled studies demonstrated the substantial effects of continuous positive airway pressure ventilation (CPAP) on a variety of physiologic and biochemical markers known to be risk factors for cardiovascular disease in patients with obstructive sleep apnea (OSA). In this pilot crossover study, we assessed (1) the feasibility of using CPAP in a group of minimally symptomatic patients with OSA, assessed through patient compliance and (2) CPAP therapy’s effect on biomarkers in these patients. Methods We studied patients with minimal daytime sleepiness who were referred to the University of British Columbia’s Hospital Sleep Clinic with suspected OSA and an apnea-hypopnea index (AHI) > 15 events/h. Patients were randomized to either CPAP or no therapy for 4 weeks followed by a washout of 4 weeks, and then a crossover to the other intervention. Fasting morning blood and urine, 24-h blood pressure (BP) measurements, and endothelial function (peak flow-mediated dilation to nitroglycerin-mediated dilation ratio) were assessed before and after each study intervention. Results Nine adult male and four female patients were studied. Mean (SD) age was 55 (7) years, mean AHI = 27.9/h, mean Epworth Sleepiness Score = 6.8 (11/13 had a score < 10), and mean BMI = 31.1 kg/m2. Mean compliance with CPAP therapy was 5.53 h/night. Compared to no therapy, potential improvements were observed with CPAP for urinary microalbumin, norepinephrine, and epinephrine to creatinine ratios (decreased by 3.51 mg/mmol, 1.70 nmol/mmol, and 0.95 nmol/mmol, respectively); 24-h BP (systolic decreased by 3.60 mmHg, diastolic by 0.70 mmHg); homeostasis model for insulin resistance score (decreased by 1.11); and endothelial function (increased by 7.4%). However, none of the above differences was significant (p > 0.10). Conclusion In this pilot study there were potential improvements in a variety of cardiovascular biomarkers with CPAP. CPAP compliance was reasonably good even though patients were not particularly sleepy. Accordingly, larger randomized controlled trials in this area appear feasible and warranted.
- 15 August 2008
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 4 (4) , 356-361
Depression and Sleep-Related Symptoms in an Adult, Indigenous, North American Population
Study Objectives:Symptoms related to sleep disorders are common and may have substantial adverse impacts on mental health. Indigenous North Americans (American Indian) are a medically vulnerable po...
- 15 August 2008
- Published by Springer Nature in Journal of Clinical Sleep Medicine
- Vol. 4 (4) , 356-361
Depression and Sleep-Related Symptoms in an Adult, Indigenous, North American Population
Study Objectives:Symptoms related to sleep disorders are common and may have substantial adverse impacts on mental health. Indigenous North Americans (American Indian) are a medically vulnerable po...
- Open Access
- 1 June 2008
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 31 (6) , 772-3
To sleep, perchance to dip: obstructive sleep apnea, blood pressure, and cardiovascular disease.
- 1 June 2008
- Published by Oxford University Press (OUP) in SLEEP
- Vol. 31 (6) , 772-3
Open AccessTo sleep, perchance to dip: obstructive sleep apnea, blood pressure, and cardiovascular disease.